SEC Filing Analysis: Vir Biotechnology, Inc. (VIR)

Executive Summary

• Trading Significance: Low
• Key Takeaway: An officer of Vir Biotechnology has filed a notice of a proposed minor sale of common stock, valued at approximately $12,300. The transaction is immaterial relative to the company's market capitalization.
• Market Impact: Negligible. This is a routine filing for a small transaction, likely related to tax obligations on vested equity compensation.

Company Information

Field	Value
Company	Vir Biotechnology, Inc.
Ticker Symbol	VIR
CIK	0001706431
Industry	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

Field	Value
Name	de Verneuil Vanina
CIK	0002036234
Title/Position	Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	144
Transaction Date	2025-11-05 (Approximate Sale Date)
Transaction Code	S (Proposed Sale)
Security Type	Common Stock
Shares Involved	2,385
Price Per Share	$5.16 (approx.)
Total Value	$12,306.60
Shares Owned After	Not specified
Ownership Type	Not specified

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$12,306.60
% of Market Cap	0.0016%
Shares Transacted	2,385
% of Shares Outstanding	0.0017%
Post-Transaction Ownership	Not specified
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The proposed sale of $12,306.60 is insignificant for a company with a market capitalization of $0.78 billion.
• Ownership Concentration: The number of shares being sold is a tiny fraction of the total shares outstanding, indicating no meaningful change in ownership structure.
• Transaction Significance: Based on the extremely low percentage of market cap and shares outstanding, this transaction is routine and carries no significant market signal. It is common for executives to sell a portion of vested shares to cover income tax liabilities.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction size is too small to have any impact on the stock price or trading volume. It is a standard procedural filing.

Volume & Sentiment

• Expected Volume Impact: None. The share amount is negligible compared to daily trading volumes.
• Sentiment Indicator: Neutral. The market will likely disregard this filing due to its small size and routine nature.

Additional Context

Transaction Notes

• Special Circumstances: The filing indicates the shares were acquired via "Restricted Stock Vesting" on November 1, 2025, as compensation. The sale is proposed under a plan adopted on June 2, 2025, suggesting it is a pre-scheduled transaction (likely a 10b5-1 plan).
• Recent Activity: The filing also notes a prior sale of 1,365 shares on November 3, 2025, reinforcing the pattern of small, periodic sales.